tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

MRTX

MRTX Upcoming Earnings Report: What to Expect?
Pre-EarningsMRTX Upcoming Earnings Report: What to Expect?
10M ago
MRTX
Bristol Myers completes acquisition of Mirati Therapeutics
PremiumThe Fly
Bristol Myers completes acquisition of Mirati Therapeutics
11M ago
BMY
MRTX
Mirati Therapeutics receives conditional authorization for KRAZATI from EC
PremiumThe Fly
Mirati Therapeutics receives conditional authorization for KRAZATI from EC
12M ago
MRTX
The biopharmaceuticals stocks to own in 2024, according to BofA
PremiumThe Fly
The biopharmaceuticals stocks to own in 2024, according to BofA
12M ago
BMY
JNJ
Bristol Myers downgraded to Neutral at BofA as more clarity on execution awaited
PremiumThe Fly
Bristol Myers downgraded to Neutral at BofA as more clarity on execution awaited
12M ago
BMY
KRTX
Mirati Therapeutics downgraded to Neutral from Buy at Citi
PremiumThe FlyMirati Therapeutics downgraded to Neutral from Buy at Citi
1y ago
BMY
MRTX
Mirati Therapeutics’ Krazati receives positive opinion in NSLC from CHMP
Premium
The Fly
Mirati Therapeutics’ Krazati receives positive opinion in NSLC from CHMP
1y ago
MRTX
Leerink downgrades Mirati to Market Perform as focus remains on acquisition
Premium
The Fly
Leerink downgrades Mirati to Market Perform as focus remains on acquisition
1y ago
BMY
MRTX
Mirati Therapeutics downgraded to Market Perform from Outperform at Leerink
PremiumThe Fly
Mirati Therapeutics downgraded to Market Perform from Outperform at Leerink
1y ago
MRTX
Mirati Therapeutics downgraded to Hold on pending buyout at Stifel
PremiumThe Fly
Mirati Therapeutics downgraded to Hold on pending buyout at Stifel
1y ago
BMY
MRTX
Mirati Therapeutics downgraded to Hold from Buy at Stifel
PremiumThe Fly
Mirati Therapeutics downgraded to Hold from Buy at Stifel
1y ago
MRTX
Mirati Therapeutics reports Q3 EPS ($2.49), consensus ($2.83)
PremiumThe Fly
Mirati Therapeutics reports Q3 EPS ($2.49), consensus ($2.83)
1y ago
MRTX
MRTX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsMRTX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
1y ago
MRTX
Mirati Therapeutics receives MHRA approval for KRAZATI
Premium
The Fly
Mirati Therapeutics receives MHRA approval for KRAZATI
1y ago
MRTX
Kura Oncology, Mirati Therapeutics enter clinical collab, supply agreement
Premium
The Fly
Kura Oncology, Mirati Therapeutics enter clinical collab, supply agreement
1y ago
KURA
MRTX
Short Report: ChargePoint, Luminar short positions at highest levels in weeks
PremiumThe Fly
Short Report: ChargePoint, Luminar short positions at highest levels in weeks
1y ago
ARQT
BTAI
Mirati Therapeutics reports updated results from the KRYSTAL-7 Phase 2 study
PremiumThe Fly
Mirati Therapeutics reports updated results from the KRYSTAL-7 Phase 2 study
1y ago
MRTX
William Blair healthcare/biotech analysts hold analyst/industry conference call
PremiumThe Fly
William Blair healthcare/biotech analysts hold analyst/industry conference call
1y ago
BMY
AMGN
William Blair healthcare/biotech analysts hold analyst/industry conference call
PremiumThe Fly
William Blair healthcare/biotech analysts hold analyst/industry conference call
1y ago
BMY
AMGN
William Blair healthcare/biotech analysts hold analyst/industry conference call
PremiumThe FlyWilliam Blair healthcare/biotech analysts hold analyst/industry conference call
1y ago
BMY
AMGN
Ideaya has positive read from Amgen PRMT5 data, says Oppenheimer
Premium
The Fly
Ideaya has positive read from Amgen PRMT5 data, says Oppenheimer
1y ago
BMY
AMGN
Amgen’s PRMT5 drug shows 5 partial responses from 31 patients, STATnews reports
Premium
The Fly
Amgen’s PRMT5 drug shows 5 partial responses from 31 patients, STATnews reports
1y ago
BMY
AMGN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >